Total Company Value: Renalytix Plc (RNLX)

Renalytix Plc (RNLX) is developing a diagnostic system for nephrological pathologies, where the integration of tests into medical practice ensures long-term customer loyalty and a stable revenue stream from consumables. This chart on GURU.Markets shows the asset value at , linking operational successes to business security provided by AI algorithms and patents. The sector is considered a safe haven, as the demand for medical innovations remains independent of global economic fluctuations.

Renalytix, plc (RNLX) - Total Company Value from 07/04/2022 to 10/30/2026

Renalytix AI (RNLX) - metric breakdowns and financial figures

- share price and expert price forecast:

Share Price Renalytix plc|RNLX - Price Target Chart

- company stock exchange capitalization indicators:

Market Value Renalytix|RNLX - Real Price to Acquire Entire Company

- business book valuation details:

Equity per Share Renalytix|RNLX - Company Book Value|Market Capitalization to Net Assets renalytix.com|RNLX - Company Total Assets

- company total debt and liquidity indicators:

- earnings and valuation multiples indicators:

RNLX - Net Income

Analysis of all company metrics:renalytix.com

When constructing a long-term portfolio, it is critical to utilize filters that exclude speculative distortions of market price. This indicator aggregates market capitalization and net debt to determine the actual business buyout value, allowing for an assessment of the financial stability of Renalytix Plc (RNLX) during the implementation of the KidneyIntelX AI platform for predictive kidney diagnostics via the company's total valuation.

Competitors of Renalytix Plc (RNLX)